Sara Assadian
YOU?
Author Swipe
View article: Association between tacrolimus blood levels and biopsy-proven acute cellular rejection in adult heart transplant recipients
Association between tacrolimus blood levels and biopsy-proven acute cellular rejection in adult heart transplant recipients Open
View article: Cardiac adverse events associated with remdesivir in COVID-19 patients: a systematic review and meta-analysis of randomised controlled trials
Cardiac adverse events associated with remdesivir in COVID-19 patients: a systematic review and meta-analysis of randomised controlled trials Open
Objectives To evaluate whether remdesivir is associated with cardiac adverse events (CAEs), addressing concerns raised by basic experiments, clinical case reports and observational studies. Design Systematic review and meta-analysis. Data …
View article: Cellular and molecular biomarkers of long COVID: a scoping review
Cellular and molecular biomarkers of long COVID: a scoping review Open
Dr. Tebbutt has received funding from the Canadian Institutes of Health Research (177747) to conduct this work. The funding source was not involved in this scoping review, or in the decision to submit this manuscript for publication.
View article: Analytical Validation of HEARTBiT: A Blood-Based Multiplex Gene Expression Profiling Assay for Exclusionary Diagnosis of Acute Cellular Rejection in Heart Transplant Patients
Analytical Validation of HEARTBiT: A Blood-Based Multiplex Gene Expression Profiling Assay for Exclusionary Diagnosis of Acute Cellular Rejection in Heart Transplant Patients Open
Background HEARTBiT is a whole blood-based gene profiling assay using the nucleic acid counting NanoString technology for the exclusionary diagnosis of acute cellular rejection in heart transplant patients. The HEARTBiT score measures the …
View article: BLOOD BIOMARKERS AND ELECTRICAL MONITORING IN ADVANCED HEART FAILURE
BLOOD BIOMARKERS AND ELECTRICAL MONITORING IN ADVANCED HEART FAILURE Open
View article: Cost-Effectiveness of a Blood-Based Biomarker Compared to Endomyocardial Biopsy for the Diagnosis of Acute Allograft Rejection
Cost-Effectiveness of a Blood-Based Biomarker Compared to Endomyocardial Biopsy for the Diagnosis of Acute Allograft Rejection Open
View article: Biomarkers Monitoring for Absence of Acute Allograft Rejection
Biomarkers Monitoring for Absence of Acute Allograft Rejection Open